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Most published reports indicate that intensified hemodialysis
results in better pregnancy outcomes. Here we studied
clinical characteristics and the outcomes of 28 pregnant
women receiving hemodialysis. We found an association
between maternal blood data and birth weight, and
gestational age and outcomes. There were 18 surviving
infants who were followed up for one year. In the others
there were 4 spontaneous abortions, 1 stillbirth, 3 neonatal
deaths and 2 deaths after birth. Analysis of blood chemistry
for 20 pregnancies from 12 weeks of gestation until delivery
showed that the average hemoglobin level was significantly
higher in the group that successfully delivered than in the
unsuccessful group. There were significant negative
relationships between the blood urea nitrogen (BUN) level
and the birth weight or gestational age in the latter cohort. A
birth weight equal to or greater than 1500 g or a gestational
age equal to or exceeding 32 weeks corresponded to BUN
levels of 48–49 mg/dl or less. Whether the low BUN is the
direct cause of the improved outcome remains to be
examined.
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The pregnancy and successful delivery in a patient receiving
maintenance hemodialysis (HD) was first reported in 1971.1
In Japan, the first successful delivery was performed in 1977.2
Since then, the number and incidence of pregnant patients
receiving dialysis have been increasing, with the outcome
being a marked improvement in infant survival. In 1999,
Toma et al.3 reported a 48.6% (36 out of 74) success rate in
Japan. Ching-Yu Chou et al.4 reported a success rate of 70.9%
(83 out of 117) for patients treated between 1990 and 2006.
These rates may indeed represent an overestimation, as large
numbers of women may have had spontaneous miscarriages
during earlier stages of their pregnancies. As the number of
renal transplantation donors is insufficient in Japan, the
duration of HD therapy is much longer than it is in other
countries.5 We have treated 33 pregnant women receiving HD
from 1986 to 2007, which is the larger number ever reported
at a single center; here, we have investigated the character-
istics of these pregnancies.
RESULTS
Outcomes of pregnancies
The outcomes of the pregnancies are shown in Table 1. Of all
28 cases studied, 18 (64.3%) resulted in surviving infants who
were followed up for a year.
Twenty-two pregnancies were preterm and only two
pregnancies were full term. The most frequent reason for
delivery was advanced labor (11 out of 22, 50.0%). The
number of cesarean section deliveries was nine (9 out of 24,
37.5%). The most frequent reason for performing a cesarean
was also a non-reassuring fetal status (6 out of 9, 66.7%).
We examined 11 pregnancies from 1986 to 1996 and 17
pregnancies from 1997 to 2007, and we compared the
outcome of pregnancies between two groups. The rates of
successful pregnancy were 63.6 versus 64.7%, respectively.
The birth weights of newborns were not significantly different
(1545.7±730.2 versus 1311.0±792.5 g, respectively;
P¼ 0.457). The gestational ages at the time of delivery were
also not significantly different (31.4±4.7 versus 26.4±10.6
weeks, respectively; P¼ 0.154).
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Of the 28 pregnancies, except for the four cases that
resulted in spontaneous abortions, the fetal growth curve of
the remaining 24 cases is shown in Figure 1. In our hospital,
most successful pregnancies were those that delivered infants
whose birth weight was 41500 g.
Maternal and neonatal complications
The maternal and neonatal complications are shown in
Table 2. Of the 11 patients who exhibited hypertension at
some time during their pregnancy, eight patients required
medications. Of the 21 infants, 9 were born with complica-
tions. The mean birth weight of these infants was
932.9±454.5 g. Of the 9 infants with complications, 8 had
a birth weight of o1500 g. Of the twenty-four newborns, 10
were light-for-date.
Maternal characteristics and birth weight
The maternal characteristics are shown in Table 3. No
statistical difference in the mean maternal age at delivery was
seen between the successful group (34.4±4.0 years) and the
unsuccessful group (32.3±4.8 years). No statistical difference
in the period of dialysis treatment was seen between the
successful group (3.6±4.1 years) and the unsuccessful group
(5.4±5.0 years). We examined the mean dialysis time during
pregnancy of 23 patients who had received regular HD before
conception, except of the patients who started HD after
conception or those who received HD only during their
pregnancy. Their mean dialysis time (h per week) was
12.7±2.5 in first trimester (n¼ 23, median 12.0), it was
15.9±3.1 in second trimester (n¼ 20, median 15.4), and it
was 18.4±2.6 in third trimester (n¼ 13, median 20.0). The
mean maximum HD time (n¼ 23) during pregnancy was
18.2±3.9 h per week. No statistical difference in the mean
maximum HD time was seen between the successful group
(19.2±3.3 h per week) and the unsuccessful group
(16.3±4.3 h per week). We could estimate the weekly dialysis
Kt/V values in 13 successful cases and 4 unsuccessful cases.
The value tended to be higher in the successful cases
(2.98±0.72) than in the unsuccessful cases (2.47±1.04). The
mean gestational age at the time of delivery was 28.3±9.0
weeks. No statistical differences in the causes of end-stage
renal disease were seen between the two groups. All the
patients used human erythropoietin (rHuEPO) or received
blood transfusions. No statistical differences in the use of
rHuEPO, iron, or blood transfusion were seen between the
two groups.
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Figure 1 | Birth weights.J: successful pregnancy, ’:
unsuccessful pregnancy. The curves for the normal birth weight
standard deviation (s.d.) were obtained from Norio S et al.6
Table 2 | Maternal and neonatal complications
Subjects Number Percent
Maternal complications
Polyhydramnios 11/28 39.3
Hypertension 11/28 39.3
Incompetent cervix 4/28 14.3
Hypotension 1/28 3.6
Neonatal complicationsa
Retinopathy of prematurity 5/21 23.8
Respiratory distress syndrome 4/21 19.0
Patent ductus arteriosus 3/21 14.3
Chronic lung disease 3/21 14.3
Anemia 2/21 9.5
Hypotension 1/21 4.8
Sepsis 1/21 4.8
Intraventricular hemorrhage 1/21 4.8
Periventricular leukomalacia 1/21 4.8
Encephalopathy 1/21 4.8
aA total of 23 neonates survived at birth. Data were available for 21 of them.
Table 1 | Outcomes of the pregnancies
Subjects Number Percent
Number of pregnancies 28
Death or survival
Spontaneous abortion 4/28 14.3
Stillbirth 1/28 3.6
Neonatal death 3/28 10.7
Infant death 2/28 7.1
Surviving infants followed up for a year 18/28 64.3
Timing of delivery
Preterm 22/24 91.7
Full term 2/24 8.3
Reasons for preterm delivery
Spontaneous preterm delivery
Advanced labor 11/22 50.0
Chorioamnionitis 2/22 9.1
Indicated preterm delivery
Non-reassuring fetal status 5/22 22.7
Intractable hypertension 3/22 13.6
Worsening of maternal condition 1/22 4.5
Mode of delivery
Vaginal 15/24 62.5
Cesarean section 9/24 37.5
Reasons for cesarean section
Non-reassuring fetal status 6/9 66.7
Poor progress 1/9 11.1
Maternal indication 2/9 22.2
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Biochemical parameters
The average of hemoglobin (Hb) level was significantly
higher in the successful group than in the unsuccessful group
(9.6±0.9 versus 8.3±1.9 g/100 ml, respectively; P¼ 0.036).
The average of blood urea nitrogen (BUN) level was
significantly lower in the successful group than in the
unsuccessful group (45.3±8.3 versus 66.9±10.9 mg/100 ml,
respectively; Po0.001). The creatinine level was also
significantly lower in the successful group than in the
unsuccessful group (6.7±1.6 versus 9.0±1.4 mg/100 ml,
respectively; P¼ 0.010). No significant differences in the
averages of albumin, potassium, calcium, or phosphate levels
were found between the two groups. The average of albumin
level decreased from 3.6±0.5 g/100 ml at about 12 weeks
of gestational age to 2.9±0.3 g/100 ml at the time of
delivery.
Dry weight
The mean increased dry weight during the second trimester
was 127.1±167.4 g per week. The mean increased dry weight
was 146.2±183.0 g per week in the successful group (n¼ 14)
and 65.0±94.3 g per week in the unsuccessful group (n¼ 3),
during the second trimester. The mean increased dry weight
was 193.6±111.0 g per week during the third trimester, but it
was only in the successful group (n¼ 11).
Association between maternal clinical and biochemical
parameters, and birth weight
Table 4 shows the association between the birth weight, and
the maternal clinical and biochemical parameters. We
observed a negative relation between the birth weight and
the BUN level (r¼0.533, P¼ 0.016). A birth weight of
1500 g corresponded to a BUN level of 49.0 mg/100 ml
(Figure 2). The maternal serum creatinine level also tended to
Table 3 | Maternal characteristics and birth weights
Variables Total Successful Group Unsuccessful Group P-value
Number 28 18 10
Maternal age (years) 33.6±4.3 34.4±4.0 32.3±4.8 NS
Duration of HD (years) 4.2±4.5 3.6±4.1 5.4±5.0 NS
Maximum HD time (h per week)a(median) 18.2±3.9 (20.0) 19.2±3.3 (20.0) 16.3±4.3 (16.0) NS
Birth weight (g)b 1414.0±759.2 1747.4±607.0 559.6±277.0 o0.001
Cause of end-stage kidney disease
Chronic glomerulonephritis 15 (53.6) 8 (44.4) 7 (70.0) NS
Type I diabetic nephropathy 3 (10.7) 1 (5.6) 2 (20.0) NS
Reflux nephropathy 3 (10.7) 3 (1.7) 0 (0.0) NS
Henoch–Schonlein purpura nephritis 2 (7.1) 2 (11.1) 0 (0.0) NS
Type II diabetic nephropathy 1 (3.6) 1 (5.6) 0 (0.0) NS
Lupus nephritis 1 (3.6) 1 (5.6) 0 (0.0) NS
Nephrotic syndrome 1 (3.6) 1 (5.6) 0 (0.0) NS
Medullary sponge kidney 1 (3.6) 1 (5.6) 0 (0.0) NS
Gestosis 1 (3.6) 0 (0.0) 1 (10.0) NS
Anemia management
Blood transfusion N(%) 9 (32.1) 5 (27.8) 4 (40.0) NS
Human erythropoietin N(%) 24 (85.7) 15 (83.3) 9 (90.0) NS
Iron N(%) 6 (21.4) 5 (27.8) 1 (10.0) NS
Biochemical Parametersc
Hemoglobin (g/100 ml) 9.3±1.3 9.6±0.9 8.3±1.9 0.036
Albumin (g/100 ml) 3.4±0.3 3.4±0.3 3.4±0.3 NS
Blood urea nitrogen (mg/100 ml) 50.7±12.9 45.3±8.3 66.9±10.9 o0.001
Creatinine (mg/100 ml) 7.3±1.9 6.7±1.6 9.0±1.4 0.010
Potassium (mEq/l) 4.1±0.4 4.1±0.3 4.4±0.5 NS
Calcium (mg/100 ml) 9.0±0.6 9.0±0.4 8.9±0.8 NS
Phosphate (mg/100 ml) 4.4±0.8 4.2±0.6 4.7±1.2 NS
HD, hemodialysis; NS, not significant (P40.05).
aOf the 23 patients who had received regular HD before conception, 15 were successful cases and 8 were unsuccessful cases.
bThe total number of infants was 25, because 3 cases underwent dilatation and curettage; 18 were successful cases and 7 were unsuccessful cases.
cWe obtained biochemical data from 20 patients; 15 were successful cases and 5 were unsuccessful cases.
Table 4 | Linear regression analysis of relationships of
maternal characteristics with birth weight and gestational
age
Birth weight Gestational age
Variables r P-value r P-value
Maternal age (years) 0.063 0.791 0.167 0.483
Duration of HD (years) 0.126 0.598 0.013 0.958
Hemoglobin (g/100 ml) 0.164 0.490 0.101 0.672
Albumin (g/100 ml) 0.085 0.738 0.098 0.699
Blood urea nitrogen (mg/100 ml) 0.533 0.016 0.504 0.023
Creatinine (mg/100 ml) 0.429 0.059 0.422 0.064
Potassium (mEq/l) 0.008 0.977 0.098 0.707
Calcium (mg/100 ml) 0.050 0.849 0.098 0.889
Phosphate (mg/100 ml) 0.266 0.301 0.292 0.255
HD, hemodialysis; r, correlation coefficient.
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be negatively correlated with the birth weight. The maternal
age, the duration of HD, and the Hb, albumin, potassium,
calcium, and phosphate levels were not correlated with the
birth weight.
Association between maternal clinical and biochemical
parameters, and gestational age
Table 4 also shows an association between the gestational age,
and maternal clinical and biochemical parameters. A negative
correlation between the gestational age and the BUN levels
was observed (r¼0.504, P¼ 0.023). The serum creatinine
levels tended to be negatively correlated with the gestational
age (r¼0.422, P¼ 0.064). A gestational age of 32 weeks
corresponded to a BUN level of 48.0 mg/100 ml (Figure 2).
The maternal age, the duration of HD, and the Hb, albumin,
potassium, calcium, and phosphate levels were not correlated
with the gestational age.
DISCUSSION
Premature delivery is the most important problem for
pregnant women on dialysis, and a high rate of neonatal
death exists. A non-reassuring fetal status was the most
frequent cause of delivery and was also a major cause of
cesarean section. One hundred fifty pregnant women with
chronic kidney disease, none of whom had received dialysis,
were studied in 1963, and the most important factor
influencing fetal mortality was reported to be the maternal
BUN level.7 A favorable fetal outcome might be due to a less
azotemic environment. An increase in the dose of HD
treatment can reduce the azotemic status of the maternal
serum. Prolonged or intensive dialysis during pregnancy
results in longer gestational periods, higher fetal birth
weights, and greater fetal survival.8–12 In our hospital, most
successful pregnancies were those that delivered infants
whose birth weight was 41500 g. We found that the BUN
level was negatively correlated with the birth weight and a
birth weight of 1500 g corresponded to a BUN of 49.0 mg/
100 ml. It is known that 32 weeks of gestation is a meaningful
time for decision making on interventions. Robertson et al.13
analyzed neonatal outcomes and concluded that the thresh-
old, defined as the gestational week at which the incidence of
complications attributable to preterm delivery became
indistinguishable from those of term infants, was between
32 and 34 weeks. We also revealed that the BUN level was
negatively correlated with the gestational age, and a
gestational age of 32 weeks corresponded to a BUN level of
48.0 mg/100 ml. Therefore, we suggest keeping the maternal
BUN level below 48 mg/100 ml. No randomized prospective
trials of pregnant women on dialysis exist, but retrospective
data have suggested that keeping a maternal pre-dialysis BUN
level below 50 mg/100 ml may be an appropriate goal.9,14 This
target was almost the same as our suggestion. For pregnant
patients with chronic kidney disease who had not received
HD and whose BUN level was maintained above 50 mg per
100 ml, we think that it is better that dialysis treatment is
started to reduce the azotemic environment. Recently, Barua
et al.12 reported the outcomes of seven pregnant women on
nocturnal HD. The mean nocturnal HD treatment time
increased to 48±5 h per week and normal physiological pre-
dialysis BUN concentrations could be maintained through-
out the pregnancies. The mean gestational age was 36.2±3.0
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Figure 2 | Linear regression analysis of relationships of
maternal blood urea nitrogen level with birth weight and
gestational age. (a) Association between birth weight and
maternal blood urea nitrogen (BUN) level. A birth weight of
1500 g corresponded to a BUN level of 49.0 mg/100 ml.
(b) Association between gestational age and maternal BUN level.
A gestational age of 32 weeks corresponded to a maternal BUN
level of 48.0 mg/100 ml.
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weeks, the mean birth weight was 2417.5±657.0 g, and there
were few maternal and fetal complications. These noteworthy
good outcomes may due to the intensive HD treatment,
which allowed the serum BUN levels to be kept within
normal range.
Delayed confirmation of pregnancy is common among
women receiving HD because these patients are often
unaware of their pregnancy, as they usually have irregular
or anovulatory menstrual cycles.15,16 In some of our patients,
conception was confirmed too late, as their BUN level was
kept high until the second trimester and their infants had
some complications. If a woman receiving HD wishes to get
pregnant, she and her attending physician should discuss the
issue before conception, and the dialysis dose should be
planned accordingly.
Iron and rHuEPO requirements have been reported to
increase in the pregnant patients receiving HD.12,14 Although
anemia is a typical feature of pregnancy, pregnant patients
may be resistant to rHuEPO because of cytokine production
during gestation.9 All the patients in our study underwent
blood transfusions or used rHuEPO. The Hb level was
significantly higher in the successful group than in the
unsuccessful group (P¼ 0.036). Holley et al.14 recommended
maintenance of the Hb level at 10–11 g/100 ml for a better
outcome of pregnancy in HD patients. Thus, the maternal
Hb level may affect fetal, neonatal, and infant survivability.
Further investigation is necessary to determine the optimal
Hb level.
The mean time between the start of HD and conception
was 4.2±4.5 years. Patients receiving long-term HD have
generally been reported to have difficulties having successful
deliveries.17 In our study, however, the duration of HD was
not statistically different between the successful group and
the unsuccessful group. One of our patients was 42 years old
at delivery, had received regular HD treatments for 18 years,
and had a successful pregnancy.
Haase et al.18 reported that in five pregnant women
receiving frequent and intense dialysis treatments (at least
24 h per week), who had high protein intakes (approximately
1.5 g/kg per day), and whose average weight gain was
282±193 g per week, the serum albumin levels improved
and their BUN levels were controlled. Another report has
recommended a protein intake of 1.2 g/kg per day.14 In our
patients, the mean serum albumin level decreased from
3.6±0.5 g per 100 ml at 12 weeks of gestational age to
2.9±0.3 g/100 ml at the time of delivery. Of the 23 alive
neonates, 10 (43.5%) were light-for-date at birth. In general,
the gain in maternal body weight among pregnant Japanese
women is about 250 g per week in the third trimester;
however, the mean weight gain of our patients was
193.6±111.0 g per week. A higher food intake and a larger
HD dose compared with our patients might be better for fetal
growth. Further consideration of the appropriate protein or
caloric intake of pregnant women receiving dialysis is needed.
Polyhydramnios is one of the most important complica-
tions affecting infant mortality, and this condition is
common in this population, although its cause is unclear.
In our study, an inappropriate maternal dry weight setting
seemed to be one of the causes of polyhydramnios. The
increase in the maternal circulating plasma volume may cause
the fetal plasma volume and the amount of fetal urine to
increase, resulting in polyhydramnios. In pregnant dialysis
patients, estimating the dry weight is even more difficult
because of pregnancy-induced weight gains and the need to
avoid maternal hypotension during treatments. We evaluated
the fetal growth and the amniotic fluid volume using
sonographic examinations, the maternal atrial natriuretic
peptide level, and the maternal blood pressure to assess the
volume status and ultrafiltration needs of the pregnant
patients undergoing HD treatment. After the first trimester,
weight gain has often been reported to be linear, with a gain
of approximately 500 g per week.19 But in our study, the
weight gain was 146.2±183.0 g per week during the second
trimester and 193.6±111.0 g per week during the third
trimester in the successful group. This difference may be
partly due to racial differences and/or a shortage of food
intake, as described above.
In our observation, success was achieved in three out of
four (75.0%) patients in whom HD was started after
conception, and in 15 out of 24 (62.5%) patients in whom
HD was started before conception. Thus, the success
rate tended to be higher in the patients in whom HD was
started after conception. Women in whom dialysis is
initiated during pregnancy may, in general, have a better
prognosis than in women treated with HD at the time of
conception. Therefore, we excluded the four patients in
whom the HD was started after conception, and found that
there was a negative correlation between the BUN and the
birth weight (P¼ 0.044, r¼0.508), and that the Hb level
tended to be higher in the successful group (9.75±0.88 g/
100 ml) than in the unsuccessful group (8.38±2.12,
P¼ 0.080).
There were several limitations of our study. Firstly, it was a
retrospective case series and it was a single-center study.
Secondly, there were a few missing data, the total number of
blood examinations was 204 points in 20 patients in this
study, and the number of lacks of both BUN and creatinine
were 13 (0.06%) points, and the number of lacks of Hb was
15 (0.07%) points, respectively. Finally, most of data were
available from gestation age of 12 weeks in our patients;
however, it may be necessary to investigate from the period of
organogenesis of the early first trimester.
We found that the maternal Hb level during pregnancy
was associated with successful pregnancy. We also found that
the maternal BUN level during pregnancy was associated
with successful pregnancy, and it was negatively correlated
with birth weight and gestational age. A birth weight of
1500 g corresponded to a BUN level of 49.0 mg/100 ml, and a
gestational age of 32 weeks corresponded to a BUN level of
48.0 mg/100 ml. We think that intensive dialysis is effective
for successful pregnancy because the low BUN level associates
with birth weight and gestational age.
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MATERIALS AND METHODS
Patients and dialysis
We sequentially examined 33 pregnancies in 31 women receiving
HD at the Tokyo Women’s Medical University Hospital from 1986 to
2007. Four pregnant women decided to terminate their pregnancies
because of social factors, and elective abortions were performed.
One woman had an extrauterine pregnancy. The remaining 28 cases
decided to continue their pregnancies and were enrolled in this
study. Twenty-three patients had received regular HD before
conception, two patients started HD after conception, two patients
with chronic kidney disease received HD only during their
pregnancy to reduce the azotemic environment, and one patient
undergoing continuous ambulatory peritoneal dialysis had combi-
nation HD treatment during her pregnancy. Four pregnancies
resulted in spontaneous abortions, one resulted in a stillbirth, three
resulted in neonatal death, two resulted in infant death, and 18
resulted in surviving infants who were followed up for 1 year.
Neonatal complications were investigated in 21 of them, for whom
the data were available. We examined the relationships between the
maternal clinical and biochemical parameters, and birth weight or
gestational age. Gestational age was determined based on last
menstrual period and standard obstetric ultrasonography. This
study was conducted in accordance with the recommendations of
the Declaration of Helsinki, and informed consent was obtained
from all participating patients. It was a retrospective case series.
Patients were delivered with the onset of active labor,
intrauterine infection, worsening of maternal condition and non-
reassuring fetal status. Cesarean sections were carried out for those
patients who had undergone cesarean section earlier, as well as those
in whom non-reassuring fetal status or fetal malpresentation was
present.
Biochemical parameters
The maternal blood examinations were performed at the start of
dialysis. We could gain biochemical data of 20 patients. Biochemical
parameters like BUN, creatinine, and Hb were investigated every 2
weeks during the period from 12 (except of two: one was from week
14 and one was from week 16) weeks of gestation age until delivery.
The weighted average values might be more important for the
outcome of pregnancy than one-point data. Therefore, the weighted
average values were used in this study. The weekly dialysis Kt/V was
calculated as reported earlier.20
Dry weight
We obtained information on dry weight throughout the pregnancies
of our patients, starting at 22–27 weeks of gestation in 17 patients
and at 28 weeks in 11 patients, and continuing until delivery. We
analyzed increased dry weight at several time points during the
second and third trimesters.
Definitions
Hypertension was defined as a systolic blood pressure of 140 mm Hg
or more, or a diastolic blood pressure of 90 mm Hg or more, and/or
the current use of antihypertensive drugs. Neonatal death was
defined as death o28 days after birth. Infant death was defined as
death from 28 days to 1 year after birth. We defined a successful
pregnancy as one in which the delivery was without maternal
mortality and the infant survived 41 year. Polyhydramnios was
defined as an amniotic fluid index of 425 cm or the presence of a
large amniotic fluid pocket of 48 cm, as measured using
ultrasonography.
Statistical analysis
Data were reported as the means (s.d.) The Student t-test was used
to compare continuous variables between the two groups. The w2 or
Fisher exact probability test was applied for categorical data. A
simple linear regression analysis was used to examine the relation-
ships between two continuous variables. A probability o0.05 was
considered significant. All statistical calculations were performed
with JMP 5.1 software (SAS for Windows, Cart, NC, USA).
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